NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Collections Health Policy and Services Research Remove constraint Collections: Health Policy and Services Research Copyright Public domain Remove constraint Copyright: Public domain

Search Results

301. Memory supplements: clarifying FDA and FTC roles could strengthen oversight and enhance consumer awareness : report to Congressional requesters

303. Generic drug user fees: application review times declined, but FDA should develop a plan for administering its unobligated user fees : report to the Chairman, Committee on Health, Education, Labor, and Pensions, U.S. Senate

304. Physician workforce: locations and types of graduate training were largely unchanged, and federal efforts may not be sufficient to meet needs : report to Congressional requesters

305. VA information technology: pharmacy system needs additional capabilities for viewing, exchanging, and using data to better serve veterans : report to Congressional committees

306. Veterans Affairs: improved management processes are necessary for it systems that better support health care : report to Congressional requesters

307. Hospital value-based purchasing: CMS should take steps to ensure lower quality hospitals do not qualify for bonuses : report to Congressional committees

308. Gulf War illness: improvements needed for VA to better understand, process, and communicate decisions on claims : report to Congressional requesters

310. Medicaid expansion: behavioral health treatment use in selected states in 2014 : report to Congressional requesters

311. Investigational new drugs: FDA has taken steps to improve the expanded access program but should further clarify how adverse events data are used : report to Congressional addressees

312. Early learning and child care: agencies have helped address fragmentation and overlap through improved coordination : report to the Chairwoman, Committee on Education and the Workforce, House of Representatives

313. Improper payments: improvements needed in CMS and IRS controls over health insurance premium tax credit : report to Congressional committees

315. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

316. Medicare: CMS should evaluate providing coverage for disposable medical devices that could substitute for durable medical equipment : report to Congressional committees

317. VA real property: planning and communication improvements could help better align facilities with veterans' needs : testimony before the Committee on Veterans' Affairs, House of Representatives

318. Early learning and child care: overview of federal investment and agency coordination : testimony before the Subcommittee on Early Childhood, Elementary, and Secondary Education, Committee on Education and the Workforce, House of Representatives

319. Gulf War illness: additional actions needed to improve VA's claims process : testimony before the Subcommittees on Oversight and Investigations and Disability Assistance and Memorial Affairs, Committee on Veterans' Affairs, House of Representatives

320. Drug discount program: update on agency efforts to improve 340B program oversight : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

321. VA health care: improvements needed in data and monitoring of clinical productivity and efficiency : testimony before the Subcommittee on Health, Committee on Veterans Affairs, House of Representatives

322. Medicare Advantage program integrity: CMS's efforts to ensure proper payments and identify and recover improper payments : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

323. Telehealth: use in Medicare and Medicaid : testimony before the Subcommittee on Agriculture, Energy, and Trade and Subcommittee on Health and Technology, Committee on Small Business, House of Representatives

324. Drug control policy: information on status of federal efforts and key issues for preventing illicit drug use : testimony before the Committee on Oversight and Government Reform, House of Representatives

325. SSA's Compassionate Allowance Initiative: improvements needed to make expedited processing of disability claims more consistent and accurate : report to the Chairman, Subcommittee on Social Security, Committee on Ways and Means, House of Representatives

326. Medicaid: states fund services for adults in institutions for mental disease using a variety of strategies : report to the Co-Chair, Caucus on International Narcotics Control, U.S. Senate

327. Health insurance marketplaces: CMS needs to improve its oversight of state IT systems' sustainability and performance : report to Congressional requesters

328. Medicaid managed care: CMS should improve oversight of access and quality in states' long-term services and supports programs : report to Congressional requesters

329. Medicare: CMS Fraud Prevention System uses claims analysis to address fraud : report to Congressional requesters

330. VA health care: opportunities exist for improving implementation and oversight of enrollment processes for veterans : report to Congressional committees

331. Affordable Care Act: IRS should mitigate limitations of data to be used for the age and gender adjustment for the tax on high-cost health plans : report to Congressional committees

332. Public health information technology: HHS has made little progress toward implementing enhanced situational awareness network capabilities : report to Congressional committees

333. Centers For Disease Control and Prevention: use of special interest projects to fund prevention research centers : report to Congressional committees

334. State health- insurance marketplaces: three states used varied data sources for eligibility and had few indications of potentially improper enrollments : report to Congressional requesters

336. VA health care quality: VA should improve the information it publicly reports on the quality of care at its medical facilities : report to Congressional addressees

337. Personal firearms: programs that promote safe storage and research on their effectiveness : report to Congressional requesters

338. SSA's Compassionate Allowance initiative: actions needed to improve the accuracy and consistency of expedited processing of disability claims : testimony before the Subcommittee on Social Security, Committee on Ways and Means, House of Representatives

339. Human trafficking: investigations in Indian country or involving Native Americans and actions needed to better report on victims served : testimony before the Committee on Indian Affairs, U.S. Senate

340. Newborn health: federal action needed to address neonatal abstinence syndrome : report to Congressional addressees

341. Biodefense: federal efforts to develop biological threat awareness : report to Congressional requesters

342. Drinking water: DOD has acted on some emerging contaminants but should improve internal reporting on regulatory compliance : report to Congressional committees

343. Veterans Health Administration: better data and evaluation could help improve physician staffing, recruitment, and retention strategies : report to Congressional addressees

344. Investigational new drugs: FDA's expanded access program : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

345. FirstNet: efforts to establish the public-safety broadband network : testimony before the Subcommittee on Emergency Preparedness, Response, and Communications, Committee on Homeland Security, House of Representatives

346. Part D plans generally include drugs commonly used by dual eligibles: 2017

348. Financial analysis 2020: Volume three, Rehabilitation, psychiatric, long-term acute care, specialty : an annual report on the financial health of Pennsylvania non-GAC hospitals

349. Financial analysis 2020: Volume two, Ambulatory surgery centers : an annual report on the financial health of Pennsylvania ambulatory surgery centers

354. Three-year hospitalization trends: opioids, alcohol, cocaine and amphetamines

355. Imported seafood safety: FDA and USDA could strengthen efforts to prevent unsafe drug residues : report to the chairman, Committee on Appropriations, U.S. Senate

356. Low-wage workers: poverty and use of selected federal social safety net programs persist among working families : report to the ranking member, Subcommittee on Primary Health and Retirement Security, Committee on Health, Education, Labor, and Pensions, U.S. Senate

357. Climate change: information on potential economic effects could help guide federal efforts to reduce fiscal exposure : report to Congressional requesters

358. Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate

359. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

360. Federal employees health benefits program: enrollment remains concentrated despite more plan offerings, and effects of adding plan types are uncertain : report to the ranking member, Committee on Oversight and Government Reform, House of Representatives

361. Counternarcotics: overview of U.S. efforts in the Western Hemisphere : report to the ranking member, Committee on Foreign Affairs, House of Representatives

362. Preventing drug abuse: low participation by pharmacies and other entities as voluntary collectors of unused prescription drugs : report to Congressional requesters

363. Low-dose radiation: interagency collaboration on planning research could improve information on health effects : testimony before the Subcommittee on Energy, Committee on Science, Space, and Technology, House of Representatives

364. High-containment laboratories: coordinated efforts needed to further strengthen oversight of select agents : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

365. Child well-being: key considerations for policymakers including the need for a federal cross-agency priority goal : a report to Congress

368. VA health care: improved policies and oversight needed for reviewing and reporting providers for quality and safety concerns : report to the chairman, Committee on Veterans' Affairs, House of Representatives

369. VA health care: improved oversight needed for reviewing and reporting providers for quality and safety concerns : testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives

370. Private school choice: federal actions needed to ensure parents are notified about changes in rights for students with disabilities : report to Congressional requesters

371. Veterans affairs contracting: improvements in buying medical and surgical supplies could yield cost savings and efficiency : report to the chairman, Committee on Veterans' Affairs, House of Representatives

372. Health insurance exchanges: changes in benchmark plans and premiums and effects of automatic re-enrollment on consumers' costs : report to Congressional requesters

373. Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters

374. Medicare and Medicaid: CMS needs to fully align its antifraud efforts with the fraud risk framework : report to Congressional addressees

375. Sexual violence: actions needed to improve DOD's efforts to address the continuum of unwanted sexual behaviors : report to the Committee on Armed Services, U.S. Senate

376. Medicaid: further action needed to expedite use of national data for program oversight : report to Congressional requesters

377. Social Security disability: additional measures and evaluation needed to enhance accuracy and consistency of hearings decisions : report to the Chairman, Subcommittee on Social Security, Committee on Ways and Means, House of Representatives

378. FDA medical device reviews: evaluation is needed to assure requests for additional information follow a least burdensome approach : report to Congressional requestors

379. Generic drugs: FDA should make public its plans to issue and revise guidance on nonbiological complex drugs : report to Congressional requesters

380. Medicaid: CMS should take additional steps to improve assessments of individuals' needs for home- and community-based services : report to Congressional requesters

381. Medicare Part B: Medicare represented at least half of the market for 22 of the 84 most expensive drugs in 2015 : report to Congressional requesters

382. Veterans affairs contracting: improvements in buying medical and surgical supplies could yield cost savings and efficiency : testimony before the Committee on Veterans' Affairs, House of Representatives

383. Prescription opioids: Medicare should expand oversight efforts to reduce the risk of harm : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

384. VA construction: actions taken to improve Denver Medical Center and other large projects' cost estimates and schedules : testimony before the Committee on Veterans' Affairs, U.S. House of Representatives

385. Immigration detention: ICE needs to strengthen oversight of informed consent for medical care : report to congressional requesters

386. Certified Community Behavioral Health Clinics demonstration program: report to Congress, 2020

387. Maternal health: Outcomes worsened and disparities persisted during the pandemic : report to congressional addressees

388. Maternal health: Availability of hospital-based obstetric care in rural areas : report to congressional committees

389. Interim cost and qualiIty findings from the national evaluation of the Certified Community Behavioral Health Clinic demonstration

390. Opioid use in long-term care settings: final report

391. Health insurance coverage and access to care among Black Americans: recent trends and key challenges

392. Resident and facility factors associated with high risk of discharge from nursing facilities, 2012-2017: final report

393. Landscape of area-level deprivation measures and other approaches to account for social risk and social determinants of health in health care payments

394. The coordinated specialty care transition study: final report

396. Data elements for research on the role of social determinants of health in Coronavirus disease 2019: infection and outcomes in the U.S

397. Improving data infrastructure for patient-centered outcomes research for people with intellectual and developmental disabilities

398. Medicare beneficiaries’ use of telehealth in 2020: trends by beneficiary characteristics and location

399. Unwinding the Medicaid continuous enrollment provision: projected enrollment effects and policy approaches

400. Health insurance coverage and access to care for immigrants: key challenges and policy options